SIGRID's Glucose Stabiliser has found an exclusive spot on the shelves of Pure Pharmacy in Miami, US.

This collaboration marks SIGRID's inaugural retail agreement in the US, emphasising its dedication to expanding its presence in the American market.

The introduction of SIGRID's Glucose Stabiliser to Pure Pharmacy's offerings comes at a time when a considerable number of individuals are either experiencing Type 2 diabetes diagnoses or turning to glucagon-like peptide-1 (GLP-1) drugs for weight loss.

While these prescription medications can be effective, they often come with a host of side effects. Recognising the demand for alternative solutions, SIGRID's supplement is designed specifically for those transitioning from GLP-1 drugs.

It aims to assist in maintaining weight and glucose levels, offering a faster and more natural approach without the need for needles or a prescription.

A healthier path forward

CEO of SIGRID, Sana Alajmovic, views this collaboration as a significant step in the company's initiative to establish a foothold in the US market.

She highlights the alignment of Pure Pharmacy's commitment to individualised care with SIGRID's overarching goal of empowering individuals to take control of their health.

Mishal Alsabbagh, founder of Pure Pharmacy, echoes this sentiment, expressing excitement about being the exclusive Miami retailer for SIGRID's Glucose Stabiliser.

He attributes the decision to the biotechnology company's dedication to years of research and innovation, particularly with its SiPore technology.

Availability and pricing

The Glucose Stabiliser is now accessible at Pure Pharmacy's physical stores, online platform, and the SIGRID website, priced at $99.

For those interested in learning more about the product and its optimal usage, Pure Pharmacy encourages customers to consult with their pharmacists.

Additional information can be found on SIGRID's website at sigridstabiliser.com, and details regarding Pure Pharmacy are available at purepharmacysobe.com.